Skip to main content
SpringerLink
Log in
Book cover

Recurrent Pregnancy Loss pp 269–282Cite as

Pregnancy After Recurrent Pregnancy Loss

  • Chapter
  • First Online:

  • 763 Accesses

Abstract

The management of pregnancy after recurrent pregnancy loss, needs a systematic approach and counselling. Of all treatment options for women with RPL, only low dose aspirin with heparin therapy in APS, has proven role. Empirical treatment should be avoided. The approach needs to be individualized and tailored according to the patient for the optimum outcome.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   149.00
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Jeve YB, Davies W. Evidence based management of recurrent miscarriages. J Human Reprod Sci. 2014;7(3):159–69. https://doi.org/10.4103/0974–1208.142475.

    Article  Google Scholar 

  2. Stirrrat GM. Recurrent miscarriage. Lancet. 1990;336:673–5.

    Article  Google Scholar 

  3. Vanden Boogard E, Kaanclorp SP, Franssen T, Mol BW, Leschot NJ, et al. Consecutive or non-consecutive recurrent miscarriage: is there any difference in carrier status? Hum Reprod. 2010;25:1411–4.

    Article  Google Scholar 

  4. The Investigation and treatment of couples with recurrent first trimester and second trimester miscarriage. Greentop guideline no. 17. April 2011.

    Google Scholar 

  5. Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98:1103–11.

    Article  Google Scholar 

  6. Jauniaux E, Farquharson RG, Christiansen OB, Exalto N. Evidence based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod. 2006;21(9):2216–22.

    Article  Google Scholar 

  7. Recurrent Pregnancy loss. ESHRE Early Pregnancy Development Group July 2017. https://www.eshre.eu/Guidelines/Guidelines/Guidelines in development/ESHRE guideline on Recurrent Pregnancy loss open for review. Last accessed on 1 Aug 2017.

  8. Lund M, Kamper-Jorgenson M, Nielson HS, Lidegaard Ø, Andersen AM, Christiansen OB. Prognosis for live birth in women with recurrent miscarriage: what is the best measure of success? Obstet Gynecol. 2012;119:37–43.

    Article  Google Scholar 

  9. Anderson AN, Wohlfart J, Chistens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ. 2000;320:1708–12.

    Article  Google Scholar 

  10. Ness RB, Grisso JA, Hirshinger N, Markovic N, Shaw LM, et al. Cocaine and tobacco use and the risk of spontaneous abortion. N Engl J Med. 1999;340:333–9.

    Article  CAS  Google Scholar 

  11. Brigham SA, Conlon C, Farquharson RG. A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod. 1999;14:2868–71.

    Article  CAS  Google Scholar 

  12. Franssen MTM, Musters AM, van der Veen F, Repping S, Leschot NJ, et al. Reproductive outcome after PGD in couples with recurrent miscarriage in specific chromosomal abnormality: a systematic review. Hum Reprod Update. 2011;17:467–75.

    Article  CAS  Google Scholar 

  13. Vissenberg R, Goddijn M. Is there a role of assisted reproductive technology in recurrent miscarriage? Sem Reprod Med. 2011;29:548–56.

    Article  Google Scholar 

  14. Cervical Cerclage. Greentop Guidelines no. 60. May 2011.

    Google Scholar 

  15. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 142: cerclage for the management of cervical insufficiency. Obstet Gynecol. 2014:123(2 Pt 1):372–379. https://doi.org/10.1097101.AOG.0000443276.68274.CC.

    Google Scholar 

  16. Antiphospholipid syndrome. ACOG Practice Bulletin, No 118. January 2011.

    Google Scholar 

  17. Yetman DL, Kutteh WH. Antiphospholipid antibody panels and recurrent pregnancy loss: prevalence of anticardiolipin antibodies compared with other antiphospholipid antibodies. Fertil Steril. 1996;66:540–6.

    Article  CAS  Google Scholar 

  18. Empson M, Lassere M, Craig J, Scott J. Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rev. 2005;3.

    Google Scholar 

  19. Sanson BJ, Lensing AW, Prins MH, Ginsberg JS, Barkagan ZS, Lavenne-Pardonge E, et al. Safety of low-molecular weight heparin in pregnancy: a systematic review. Thromb Haemost. 1999;81:668–72.

    Article  CAS  Google Scholar 

  20. Pettila V, Leinonen P, Markkola A, Hiilesmaa V, Kaaja R. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thromb Haemost. 2002;87:182–6.

    Article  CAS  Google Scholar 

  21. James DK, Steer PJ, Weiner CP, Gonik B, Crowther C, Robson S. Chapter 6. Recurrent miscarriage. In:High risk pregnancy, management options. 4th ed. London: Elsevier; 2011. p. 75–96.

    Google Scholar 

  22. Thromboembolism in pregnancy. ACOG Practice Bulletin number 123. September 2011.

    Google Scholar 

  23. Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. 2006;(2):CD000112.

    Google Scholar 

  24. Stephensen MD, Dreher K, Houlihan E, Wu V. Prevention of unexplained recurrent abortion using intravenous immunoglobulin: a prospective randomized, double blind, placebo-controlled trial. Am J Reprod Immunol. 1998;39:82–8.

    Article  Google Scholar 

  25. Ata B, Tan SL, Shehata F, Holzer H, Buckett W. A systematic review of intravenous immunoglobulin for treatment of unexplained recurrent miscarriage. Fertil Steril. 2011;95:1080–5.

    Article  CAS  Google Scholar 

  26. Hutton B, Sharma R, Fergusson D, Tinmouth A, Hebert P, Jamieson J, Walker M. Use of intravenous immunoglobulin for treatment of recurrent miscarriage: a systematic review. Br J Obstet Gynecol. 2007;114:134–42.

    Article  CAS  Google Scholar 

  27. ACOG Practice Bulletin Number 145: antepartum fetal surveillance, July 2014. Obstet Gynecol. 2014;124:182–92.

    Google Scholar 

  28. Antenatal corticosteroids to reduce neonatal morbidity and mortality. Green Top Guidelines No 7. October 2010.

    Google Scholar 

  29. Hofmeyr GJ. Antenatal corticosteroids foe women at risk of preterm birth: RHL commentary (Last Revised: 2 February 2009). The WHO Reproductive Health Library; Geneva: World Health Organization.

    Google Scholar 

  30. Goonewardene M, Rameez MFM, Kaluarachchi A, Perera H. WHO recommendations for induction of labour: RHL commentary (Last Revised: 1 November 2011). The WHO Reproductive Health Library; Geneva: World Health Organization.

    Google Scholar 

  31. Caughey AB, Bishop JT. Maternal complications of pregnancy increase beyond 40 weeks of gestation in low risk women. J Perinatol. 2006;26:540–5.

    Article  CAS  Google Scholar 

  32. Nicholson MD, Kellar LC, Bennet I, et al. The active management of risk in multiparous pregnancy at term: association between a higher prevention labour induction rate and improved birth outcomes. Am J Obstetr Gynaecol. 2009;200:250.e1–250.e13.

    Article  Google Scholar 

  33. Nicholson MD, Kellar LC, Cronholm PF, Macones GA. Active management of risk in pregnancy at term in an urban population: an association between a higher induction of labor rate and a lower caesarean delivery rate. Am J Obstetr Gynaecol. 2004;191:1516–28.

    Article  Google Scholar 

  34. ACOG Practice Bulletin. Antepartum surveillance. Number 145. July 2014.

    Google Scholar 

  35. Medical Eligibility Criteria (MEC) for different contraceptive methods (Medical Eligibility Criteria for contraceptive use). 5th ed. 2015.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Obstetrics and Gynecology, Vardhman Mahavir Medical College and Safdarjung Hospital, Delhi, India

    Divya Pandey

Authors
  1. Divya Pandey
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Divya Pandey .

Editor information

Editors and Affiliations

  1. Department of Obstetrics & Gynecology, Babu Jagjivan Ram Memorial Hospital, New Delhi, India

    Sumita Mehta

  2. Department of Obstetrics and Gynecology, UCMS & GTB Hospital, New Delhi, India

    Bindiya Gupta

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pandey, D. (2018). Pregnancy After Recurrent Pregnancy Loss. In: Mehta, S., Gupta, B. (eds) Recurrent Pregnancy Loss. Springer, Singapore. https://doi.org/10.1007/978-981-10-7338-0_21

Download citation

  • DOI: https://doi.org/10.1007/978-981-10-7338-0_21

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-10-7337-3

  • Online ISBN: 978-981-10-7338-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation